Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...

Regeneron has reported positive outcomes from the Phase III trial of Eylea HD in treating individuals with macular oedema ...

For those who smoke, this long-term habit can damage parts of your eye, contributing to serious conditions such as macular ...

These are the best vitamins and supplements for eye health, which are great for supporting your vision and helping you take ...

D Molecular (FDMT) presented 52-week wet age-related macular degeneration Phase IIb results at this weekend’s Angiogenesis, Exudation, and ...

Hong Kong biotech start-up works with university partners to conduct global clinical trials studying prevalent eye diseases.

Occasionally, treatments come along that are of greater interest to patients than to doctors.Drops for treating presbyopia ...

Clearside Biomedical (CLSD) announces that two subgroup analyses were presented from the ODYSSEY Phase 2b clinical trial at the Angiogenesis, ...

The following is a summary of “High Density Lipoproteins Associate with Age-Related Macular Degeneration in the All of Us Research Program,” published in the January 2025 issue of Ophthalmology by ...

NIH’s decision to cut what it pays universities and other entities for indirect costs associated with scientific research ...

This new machine learning technology could help farmers optimize harvest timing and improve the quality of the produce.